This article from Biotech Metro highlights how Reselute is developing innovative medical device technology designed to address complex orthopedic infections. The feature explores the company’s

Reselute is proud to announce that the company has been awarded a National Institutes of Health (NIH) FastTrack SBIR combined Phase I/II grant. This significant

The Reselution™ Tibial Intramedullary Fixation System has received FDA Breakthrough Device Designation, recognizing its potential to provide more effective treatment or prevention of serious conditions

This article from Duke University’s Office of Technology Commercialization highlights how Cambre Kelly’s collaboration with a Duke faculty member led to the creation of multiple

This featured video from Ortho Innovators highlights Cambre Kelly’s perspective on biomedical engineering and innovation within orthopedics. The conversation explores emerging technologies, leadership in medtech, and the

In Catching Up with Cambre Kelly, Ph.D., BoneZone reconnects with Dr. Kelly to discuss her career progression, research interests, and evolving role in orthopedic innovation.